Gongyan Chen

机构：Harbin Medical University, Third Affiliated Hospital of Harbin Medical University

发表论文 14 篇 · 总被引 393 次 · h-index 6

代表论文

• Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer (2024 · Journal of Clinical Oncology · 被引 155)
• A PET imaging approach for determining EGFR mutation status for improved lung cancer patient management (2018 · Science Translational Medicine · 被引 102)
• China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version) (2016 · Asia-Pacific Journal of Clinical Oncology · 被引 44)
• Atezolizumab plus bevacizumab and chemotherapy in metastatic nonsquamous NSCLC: the randomized double-blind phase 3 IMpower151 trial (2025 · Nature Medicine · 被引 34)
• [China Experts Consensus on the Diagnosis and Treatment of Brain Metastases of Lung Cancer (2017 version)]. (2017 · PubMed · 被引 27)
• Anlotinib for patients with small cell lung cancer and baseline liver metastases: A post hoc analysis of the ALTER 1202 trial (2021 · Cancer Medicine · 被引 21)